Drug developer Redx Pharma PLC (AIM:REDX) appointed the former chief medical officer of the drug giant AbbVie as its new independent director.
Dr Rob Scott joins the board immediately.
In his former role he oversaw 14 major regulatory approvals.
Chair, Dr Jane Griffiths, said Scott would bring a ‘clinical development and regulatory perspective’ as Redx builds its portfolio of assets.
“The board and I look forward to working with Rob to ensure that we continue to grow Redx into a successful biotech company focused on the treatment of cancer and fibrotic disease," she added.